Bajaj HealthCare Limited (BAJAJHCARE.BO)

324.15 +8.30 (+2.63%) At close: 03:47PM IST

Bajaj HealthCare Limited

602-606, Bhoomi Velocity Infotech Park
Plot No: B-39, B-39A, B-39 A/1 Road No. 23, Wagle Industrial Estate Thane (West)
Thane 400604
India
91 22 6617 7400
https://www.bajajhealth.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Description

Bajaj HealthCare Limited, a pharmaceutical company, research, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides formulations in the form of tablets, capsules, and oral powder, as well as intermediates and impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Corporate governance

Bajaj HealthCare Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.